Industry Portals
Biotechnical Industry News
Integer a velit nec risus malesuada imperdiet id et odio. Nunc sit amet mauris dapibus, feugiat diam eget, suscipit, nam gravida nulla eget turpis commodo.
Young & Partners 2019 Chemical Conference: Anla Cheng and Jeremy Goldkorn of SupChina: Perspectives and Update on China
Anla Cheng, Founder and CEO, SupChina, Jeremy Goldkorn, Editor-in-Chief, SupChina, moderated by Peter Young, CEO, Young & Partners
Megadeals done, M&A volumes remain flat (Chemical Week July 22, 2019 issue)
Editor-in-Chief interviews Peter Young about the Chemical M&A market developments
Pharma and Biotech – Financial Check and Outlook (Y&P article in Pharma Exec, July 2019 issue)
Young & Partners examples the strategic, M&A, and financial health of Biopharma
Chemicals M&A in Transition (Y&P article in ICIS Chemical Business, June 14-20, 2019)
Analysis of the M&A market: Shifting Valuations, Healthy Volumes, Death of Mega Deals
M&A Values Hold Strong But Volume Dips (Chemweek March 11-18, 2019)
Young & Partners data shows high total dollars in 2018, but underlying volumes slid
Chemicals M&A at Inflection Point (Y&P article in ICIS March 1-7, 2019 issue)
Transaction trends differ greatly, depending on sector and geography.
CFIUS Reform’s Impact on Biopharma (Phama Exec February 2019 issue)
What the new rules mean for Chinese-related investments and acquisitions in the US
Chemical Week – Young & Partners M&A Interview (Nov 5, 2018 issue)
Young & Partners looks at the chemical M&A market and the role of the mega deals
Good, bad news for Chemical Financing (Y&P article in ICIS Chemical Business) Nov 2 – Nov 8, 2018 issue
Young & Partners’ provides its analysis of what is happening in the stock market and financing worlds.
Business Check – Industry Financial Pulse (Young & Partners article in Pharm Exec Nov 2018)
An in depth look at strategic, M&A and financial trends for Pharma and Biotech
Chemical M&A – Reality vs Myth (Y&P article in ICIS Chemical Business) Oct 26 – Nov 1, 2018 issue
Young & Partners looks at the big picture trends, how they differ from conventional views, and their implications for management.
The Rise of China Biopharma (Pharmaceutical Executive – July issue)
Young & Partners analyzes the rise in China's biopharma industry, both positive and negative
Dr. Spielberg, former Deputy Commissioner of the FDA, joins Young & Partners (June 11, 2018)
Young & Partners adds to its deep regulatory and biopharma expertise
Banker: Value of Closed M&A Soars in 2017 due to Mega Deals (Feb 12 – 19, 2018, Chemical Week)
Peter Young of Young & Partners interviewed about the nuances of the Chemical M&A market in 2017
Stock Market and Financing – Strong with a Twist (ICIS Chemical Business, Feb 2, 2018 issue)
2017 was great for chemical stock market performance and financing, but not for everyone